24 related articles for article (PubMed ID: 19538887)
1. miR-29b expression is associated with disease-free survival in patients with ovarian serous carcinoma.
Flavin R; Smyth P; Barrett C; Russell S; Wen H; Wei J; Laios A; O'Toole S; Ring M; Denning K; Li J; Aherne S; Sammarae D; Aziz NA; Alhadi A; Finn SP; Loda M; B S; Sheils O; O'Leary JJ
Int J Gynecol Cancer; 2009 May; 19(4):641-7. PubMed ID: 19509563
[TBL] [Abstract][Full Text] [Related]
2. Low grade serous ovarian cancer: Unpicking drivers of outcome.
Gourley C; Hollis RL
Gynecol Oncol; 2022 Nov; 167(2):137-138. PubMed ID: 37850592
[No Abstract] [Full Text] [Related]
3. Evaluation of the Potential Diagnostic Utility of the Determination of Selected Caspases-Markers Involved in the Regulation of Apoptosis-In Patients with Ovarian Cancer.
Mielczarek-Palacz A; Jasińska S; Strzelec A
Diagnostics (Basel); 2021 Apr; 11(4):. PubMed ID: 33919909
[TBL] [Abstract][Full Text] [Related]
4. Ovarian cancer during fertility follow-up.
Jiménez A; Chiva L
Int J Gynecol Cancer; 2024 Mar; ():. PubMed ID: 38531537
[No Abstract] [Full Text] [Related]
5. [Significance of expression of THY1 protein in epithelial ovarian cancer].
Yang GF; Chao K; Li XM; Rao HL; Deng HX; Wu HM; Xie D
Zhonghua Zhong Liu Za Zhi; 2009 Mar; 31(3):203-7. PubMed ID: 19615261
[TBL] [Abstract][Full Text] [Related]
6. Expression of glucose transporter protein 1 and p63 in serous ovarian tumor.
Cai Y; Zhai JJ; Feng BB; Duan XZ; He XJ
J Obstet Gynaecol Res; 2014 Jul; 40(7):1925-30. PubMed ID: 25056472
[TBL] [Abstract][Full Text] [Related]
7. [Expression and significance of GLUT-1 and DNA-PKcs in serous ovarian tumors].
Cai Y; Shao SL; Wang QH; Yan LJ; Wang XY; Wang LX
Ai Zheng; 2007 Nov; 26(11):1188-93. PubMed ID: 17991316
[TBL] [Abstract][Full Text] [Related]
8. Nanog is highly expressed in ovarian serous cystadenocarcinoma and correlated with clinical stage and pathological grade.
Pan Y; Jiao J; Zhou C; Cheng Q; Hu Y; Chen H
Pathobiology; 2010; 77(6):283-8. PubMed ID: 21266826
[TBL] [Abstract][Full Text] [Related]
9. [Expression and clinical relevance of ARHI, STAT3 and E2F1 in ovarian serous carcinoma].
Zhang J; Li YH; Cui AR; Wang JL; Cheng JX; Wang SJ
Zhonghua Zhong Liu Za Zhi; 2008 Dec; 30(12):905-9. PubMed ID: 19173990
[TBL] [Abstract][Full Text] [Related]
10. [Expression of THY1 gene in epithelial ovarian cancer].
Zeng LQ; Peng ZL; Duan ZL
Zhonghua Zhong Liu Za Zhi; 2009 Feb; 31(2):118-20. PubMed ID: 19538887
[TBL] [Abstract][Full Text] [Related]
11. Serous ovarian cancer signaling pathways.
Kotsopoulos IC; Papanikolaou A; Lambropoulos AF; Papazisis KT; Tsolakidis D; Touplikioti P; Tarlatzis BC
Int J Gynecol Cancer; 2014 Mar; 24(3):410-7. PubMed ID: 24476895
[TBL] [Abstract][Full Text] [Related]
12. Bilateral ovarian fibromas with concomitant unilateral serous cystadenoma: a rare case with review of literature.
Singh V; Kaur N; Mandal S; Khurana N; Bhasin S
J Obstet Gynaecol; 2019 Oct; 39(7):1027-1029. PubMed ID: 31303118
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
